The discovery of the Bcl-2 protein family, as well as p53 and its involvement in regulating apoptosis, and the CD95 (also known as FAS or APO1) pathway, led to an understanding of the molecular ...

Subsequent studies showed that BCL-2 was not overexpressed in all melanomas ... Agents that specifically target mediators of apoptosis are most likely to be active when the mediators are both ...

From early development to old age, cell death is a part of life. Without enough of a critical type of cell death known as ...

Rockville, Maryland Tuesday, November 19, 2024, 13:00 Hrs [IST] ...

Ascentage Pharma's BCL-2 inhibitor, lisaftoclax, is under China’s Priority Review for chronic lymphocytic leukemia and small ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...